Open Access

Heat‑induced antigen retrieval in fluorescence in situ hybridization: An effective approach enhancing signal intensity in poor‑quality FFPE sections

  • Authors:
    • Qiuxiao Yu
    • Chi Zhang
    • Wenting Huang
    • Li Li
  • View Affiliations

  • Published online on: October 25, 2021     https://doi.org/10.3892/etm.2021.10915
  • Article Number: 1480
  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fluorescence in situ hybridization (FISH) serves as an ancillary tool for assessing chromosomal abnormalities and is important in differential diagnoses and treatment decisions. In clinical practice, pathologists encounter unsatisfactory formalin‑fixed paraffin‑embedded (FFPE) sections exhibiting weak fluorescence signals, mostly due to inappropriate tissue processing or preservation, leading to interpretation difficulties. For the present study, FFPE samples for which conventional FISH failed were collected. Instead of a pretreatment step using a commercial kit, heat‑induced antigen retrieval (HIAR) was introduced using either citrate buffer or Tris‑EDTA buffer, while the subsequent experimental workflow remained unchanged. After HIAR‑assisted FISH, the hybridization efficiency and signal intensity were markedly enhanced and no difference in signal adequacy was observed when comparing the effect of the two AR solutions. The present study demonstrated that HIAR is a reliable tool for FISH, particularly for poor‑quality FFPE sections yielding weak or no fluorescence signals in the conventional analysis.

Introduction

Fluorescence in situ hybridization (FISH) is a well-established technique in pathology laboratories for the identification of recurrent tumor-specific chromosomal translocations and copy number variations, assisting in clinical diagnosis and the selection of treatment strategies (1). FISH offers distinct advantages over other molecular diagnostic methods. Unlike reverse transcription-polymerase chain reaction (RT-PCR) or next-generation sequencing (NGS), FISH utilizes fluorophore-coupled probes that specifically bind to complementary sequences and provides detailed intracellular localization of target genes, which is particularly important when evaluating tissues with small tumor volumes or tumors consisting of multiple mixed cells (2,3). For gene rearrangement, a FISH break-apart probe is capable of detecting all possible rearrangements involving a common breakpoint region despite corresponding fusion partners or variants. By contrast, the RT-PCR technique requires multiple pairs of primers to identify certain known rearrangements, which is time-consuming and relatively inefficient (4).

There are also limitations with FISH, which may result in experimental failure or diagnostic errors. The lack of standard interpretation guidelines for multiple FISH probes leads to difficulties in explaining atypical, abnormal signal patterns, such as isolated or unbalanced signals (5). Furthermore, it is necessary for clinical laboratories to establish an analytical normal cutoff value for individual probes, which may vary among different institutions. Another challenge for FISH detection is the sample quality, which is predominantly determined by the tissue processing procedure and tissue component. Fixation time, storage, decalcifying agents, and collagen and extracellular matrix abundance may influence the intensity of FISH signals and therefore hinder pathological diagnosis (4). In clinical practice, one obstacle for FISH is that not all pathology archives are desirable. Unsatisfactory paraffin blocks or FFPE sections always lead to interpretation failure and difficulties in clinical diagnosis. To solve this problem, conventional FISH procedures urgently require to be improved.

Heat-induced antigen retrieval (HIAR) is an effective method widely applied in immunohistochemistry to unmask antigens in FFPE sections (6). Prompted by this simple technique, the present study provided a modified FISH protocol. In the pretreatment step, HIAR with either citrate or Tris-EDTA buffer was applied to poor-quality FFPE sections that failed in the conventional pathology workflow, and the detection validity and signal intensity markedly improved. In addition, evaluation data acquired from two HIAR-assisted FISH methods were compared and the same interpretation results were obtained. Overall, this protocol is sufficient for enhancing FISH signals and produces reliable results.

Materials and methods

Tissue samples

Among 328 archived tumor tissues sent to the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital (Shenzhen, China) for FISH detection from January 2020 to May 2021, seven FFPE sections failed in conventional FISH experiments and HIAR-FISH was performed for these samples to assess the efficacy of the modified protocol. Furthermore, four adequately handled specimens were randomly selected to evaluate whether HIAR would affect the original signal pattern. The median age of the patients (9 male and 2 female) was 45 years. Our study cohort consisted of nine cases of soft tissue sarcomas and two cases of microphthalmia family translocation renal cell carcinoma. All samples were excision tissues and sectioned at 4-µm thickness for detection. Patient clinical and pathological characteristics are summarized in Table I.

Table I

Clinicopathological information of the cases.

Table I

Clinicopathological information of the cases.

Case no.SexAge, yearsSiteSpecimen typeDiagnosis
1M30Right shoulderExcisionClear cell sarcoma
2F34Left kidneyExcisionMiT family translocation renal cell carcinoma
3M56Right kidneyExcisionMiT family translocation renal cell carcinoma
4M27Left footExcisionSynovial sarcoma
5M33Right thighExcisionMyxoid liposarcoma
6M45Right thighExcisionMyxoid liposarcoma
7M55Right thighExcisionPleomorphic liposarcoma
8M44Chest wallExcisionHigh-grade fibrosarcoma
9M54RetroperitonealExcisionWell-differentiated liposarcoma
10M48Left thighExcisionLow-grade fibromyxoid sarcoma
11F53Abdominal wallExcisionUndifferentiated small round cell sarcoma

[i] M, male; F, female; MiT, microphthalmia.

FISH protocol

FISH experiments were performed on the interphase nuclei of 4-µm FFPE sections using commercial probe kits, including synovial sarcoma translocation chromosome 18 (SS18), Ewing sarcoma breakpoint region 1 gene (EWSR1), DNA damage inducible transcript 3 (DDIT3), transcription factor binding to IGHM enhancer 3 (TFE3) and murine double minute-2 (MDM2). The detailed probe information is listed in Table II, and all probes were diluted 1:10 with LSI/WCP hybridization buffer (Abbott Molecular, Inc.).

Table II

Information on the probes.

Table II

Information on the probes.

ProbeTypeChromosome locationManufacturerLot no.
SS18Break-apart18q11.2Abbott Molecular, Inc.30-608250/R3
EWSR1Break-apart22q12Abbott Molecular, Inc.30-608248/R4
DDIT3Break-apart12q13Abbott Molecular, Inc.30-608246/R3
TFE3Break-apartXp11.23ZytoVisionZ-2109
MDM2/CEP12Amplification12q15Abbott Molecular, Inc.30-608268/R2

[i] SS18, synovial sarcoma translocation chromosome 18; EWSR1, Ewing sarcoma breakpoint region 1 gene; DDIT3, DNA damage inducible transcript 3; TFE3, transcription factor binding to IGHM enhancer 3; MDM2, murine double minute-2; CEP12, chromosome enumeration probe 12.

Conventional FISH was performed using a Vysis paraffin pretreatment IV & post hybridization wash buffer kit (Abbott Molecular, Inc.) following the manufacturer's protocol, as illustrated in Fig. 1. In brief, the FFPE slides were dewaxed in 100% xylene, dehydrated in 100% ethanol and dried in air. For tissue pretreatment, the slides were immersed in pretreatment solution containing 1 N sodium thiocyanate (NaSCN) at 80˚C for 10-15 min and then soaked in purified water for 3 min. Subsequently, the excess water along the edges of the slides was removed with a paper towel, followed by enzymatic digestion using pepsin buffer (1.5 mg/ml) for 10-15 min at 37˚C. The slides were then immersed in purified water for 3 min at room temperature. After ethanol gradient dehydration, diluted probes were applied to the target tissue areas and the slides were processed with the ThermoBrite Denaturation/Hybridization System (Abbott Molecular, Inc.) using the following program: 10 min at 82˚C and 12-16 h at 37˚C. The next day, the slides were rapidly washed with 2X saline sodium citrate buffer (SSC)/0.1% nonidet P (NP)-40 at ambient temperature for 3-5 min and 0.7X SSC/0.3% NP-40 at 74˚C for 2 min. After air-drying in the dark, the tissues were counterstained using DAPI to visualize nuclei. FISH signals were viewed with suitable filter sets under a fluorescence microscope (magnification, x600; Leica Microsystems GmbH) and the images were captured using a Bioview Allegro Plus System (Abbott Molecular, Inc.) with the same parameter settings.

HIAR in FISH

HIAR was applied for slides exhibiting unsatisfactory signals in conventional FISH (Fig. 1). In the present study, two AR solutions of different pH values were used: Citrate buffer (pH=6.0) and Tris-EDTA buffer (pH=9.0). In detail, AR solution was added into a pressure cooker on a hotplate. The lid of the cooker was simply rested on top at this point. After boiling, slides were rapidly immersed in AR solution and the cooker lid was secured. Once the cooker reached the full pressure, conditions were maintained for 2 min. Subsequently, the pressure cooker was placed in an empty sink and the pressure valve was carefully released. Once depressurized, the lid was removed and slides were cooled at room temperature for 60 min.

FISH signal enumeration

For each case, the slide adequacy was evaluated according to three criteria: i) The background should be dark and relatively free of fluorescence particles; ii) the fluorescence signals under both channels should appear unequivocal, bright and easily identified; and iii) the nuclei morphology should be intact and distinguishable. Only slides with these features were interpreted.

A minimum of 50 non-overlapping nuclei were counted for each case independently by two pathologists (16 and 2 years of experience, respectively) in a blinded manner. For break-apart probes targeting EWSR1, DDIT3, SS18 and TFE3, the typical rearrangement pattern was 1F/1G/1O (1 fusion, 1 green, 1 orange) and the cell was considered positive when at least one set of green and orange signals were separated at ≥2 signal diameters apart. Cells without rearrangement exhibited fused or adjacent (distance <2 signal diameters) green and orange signals. The cutoff value for each break-apart probe was 15% in our laboratory, which was established as recommended by the American College of Medical Genetics guidelines (1,7). For the MDM2/CEP12 probe, amplification was considered to have occurred in cells with an MDM2 (orange)/CEP12 (green) ratio ≥2.0.

Statistical analysis

To quantify the hybridization efficiency of different FISH protocols, three captured views of individual samples were randomly selected and quantification of i) the total cell number, ii) number of cells with clear fluorescence signals (either green or orange), and iii) number of cells conforming to interpretation criteria above was performed. The percentage of cells is presented as the mean ± standard error of the mean. All analyses were performed using GraphPad Prism software 5.0 (GraphPad Software, Inc.).

Results

HIAR markedly promotes FISH efficiency in detecting fluorescence signals

In conventional FISH experiments using commercial pretreatment kits, all seven pathology samples failed to meet the interpretation standard because the density ratio of signal to background was low in either the orange or green channel, making it impossible to identify signal patterns. To obtain satisfactory results, HIAR was introduced to replace the pretreatment step. Of the seven samples, five were processed with both citrate buffer and Tris-EDTA buffer, while the remaining two samples were only treated with Tris-EDTA buffer due to the lack of FFPE slides provided by external medical centers. As illustrated in Fig. 2A-F, FISH analysis was successfully performed on six of the slides, which yielded clear and bright fluorescence signals in both the orange and green channels with intact cell nucleus morphology. The other sample hybridized with DDIT3 only exhibited a marginal improvement after HIAR using either HIAR buffer (data not shown). To directly illustrate the enhanced hybridization efficiency after antigen retrieval, the ratio of cells satisfying the aforementioned interpretation criteria were quantified as indicated, as well as cells exhibiting fluorescence signals, either orange or green. As depicted in Fig. 3A, only case 6 contained several interpretable cells (<10%) after the conventional FISH experiment, but the retrieval treatment with either Tris-EDTA or citrate buffer significantly increased the ratio of non-overlapped cells clearly exhibiting both green and orange signals (P<0.001). Furthermore, the signal retrieval effect of the two buffers was compared and no significant difference was observed in cases 1-4. Similar results were obtained after calculating the percentage of cells exhibiting either a green or an orange signal (Fig. 3B). These data indicated an encouraging effect of HIAR in facilitating probe binding and fluorescence signal restoration for poor-quality FFPE slides.

Consistent interpretation results obtained with two HIAR-FISH methods

After assessing the signal quality of HIAR-FISH, two experienced pathologists interpreted the FISH slides separately to compare the results from the two assays. The detailed counting results and final diagnosis are listed in Table III. For slides 1-4, stable results were obtained from two HIAR-FISH experiments, suggesting that these two AR solutions significantly amplified fluorescence intensity without influencing signal patterns. In addition, the interpretation results for all six samples provided by the two pathologists had high consistency.

Table III

Fluorescence in situ hybridization interpretation results of poor-quality FFPE sections.

Table III

Fluorescence in situ hybridization interpretation results of poor-quality FFPE sections.

Case/probeHIER bufferPathologist 1Pathologist 2
1/EWSR1Tris-EDTA bufferPositivePositive
  (1G/1O/1-3F, 30%; 3-4F, 52%; other, 18%)(1G/1O/1-3F, 22%; 3-4F, 52%; other, 26%)
 Citrate bufferPositivePositive
  (1G/1O/1-3F, 28%; 3-4F, 44%; other, 28%)(1G/1O/1-3F, 30%; 3-4F, 40%; other, 30%)
2/TFE3Tris-EDTA bufferPositivePositive
  (1G/1O/1F, 72%; 2F, 12%; other, 16%)(1G/1O/1F, 64%; 1-2F, 8%; other, 28%)
 Citrate bufferPositivePositive
  (1G/1O/1F, 62%, 1G/1O, 20%; 1-2F, 8%; other, 10%)(1G/1O/1F, 52%, 1G/1O, 1-2F, 12%; other, 24%)
3/TFE3Tris-EDTA bufferNegativeNegative
  (1F, 82%; 2F, 18%)(1F, 86%; 2F, 14%)
 Citrate bufferNegativeNegative
  (1F, 78%; 2F, 22%)(1F, 82%; 2F, 18%)
4/SS18Tris-EDTA bufferPositivePositive
  (1G/1O/1F, 24%; atypical break-apart patterns, 60%; 1-2F, 16%)(1G/1O/1F, 20%; atypical break-apart patterns, 60%; 1-2F, 20%)
 Citrate bufferPositivePositive
  (1G/1O/1F, 20%; atypical break-apart patterns, 58% 1-2F, 22%)(1G/1O/1F, 20%; atypical break-apart patterns, 58%; 1-2F, 22%)
5/DDIT3Tris-EDTA bufferPositivePositive
  (1G/1O/1F, 48%; 2F, 30%; other, 22%)(1G/1O/1F, 44%; 1-2F, 36%; other, 20%)
 Citrate bufferN/AN/A
6/MDM2Tris-EDTA bufferNegativeNegative
  (MDM2/cell, 1.6a; CEP12/cell, 1.7b; MDM2/CEP12, 0.94c)(MDM2/cell, 1.66; MDM2/CEP12, 1.0)
 Citrate bufferN/AN/A

[i] aThe average copy number of the MDM2 gene in each tumor cell;

[ii] bthe average copy number of chromosome 12 in each tumor cell; and

[iii] cthe amplification ratio of the MDM2 gene in each tumor cell. N/A, not available; HIAR, heat-induced antigen retrieval; F, fusion; G, green; O, orange; EWSR1, Ewing sarcoma breakpoint region 1 gene; TFE3, transcription factor binding to IGHM enhancer 3; SS18, synovial sarcoma translocation chromosome 18; DDIT3, DNA damage inducible transcript 3; MDM2, murine double minute-2; CEP12, chromosome enumeration probe 12.

HIAR does not affect the signal of adequately handled samples

To evaluate the effect of HIAR on well-handled samples, 4 specimens exhibiting adequate signals after conventional FISH were randomly selected and HIAR was applied to them. First, the signal intensity of these slides was compared and no significant difference was observed between conventional and HIAR-FISH using either citrate or Tris-EDTA buffer (Fig. 4A-D). The two pathologists then interpreted the FISH slides and similar results were obtained after introducing HIAR (Table IV). These data indicated that HIAR did not influence the results of FISH in adequately handled samples.

Table IV

Fluorescence in situ hybridization interpretation results of adequately handled samples.

Table IV

Fluorescence in situ hybridization interpretation results of adequately handled samples.

Case/probeHIER bufferPathologist 1Pathologist 2
8/SS18Tris-EDTA bufferNegativeNegative
  (2F, 78%; 3F, 8%; other, 14%)(2F, 80%; 3F, 10%; other, 10%)
 Citrate bufferNegativeNegative
  (2F, 80%; 3F, 8%; other, 12%)(2F, 76%; 3F, 12%; other, 12%)
9/MDM2Tris-EDTA bufferPositivePositive
  (MDM2/cell, 21.8a; CEP12/cell, 2.2b; MDM2/CEP12, 9.91c)(MDM2/cell, 23.3; CEP12/cell, 2.4; MDM2/CEP12, 9.71)
 Citrate bufferPositivePositive
  (MDM2/cell, 22.6; CEP12/cell, 2.5; MDM2/CEP12, 9.04)(MDM2/cell, 22.9; CEP12/cell, 1.9; MDM2/CEP12, 12.05)
10/DDIT3Tris-EDTA bufferNegativeNegative
  (2F, 64%; 3F, 10%;1F, 10%; other, 16%)(2F, 68%; 3F, 10%; 1F, 12%; other, 10%)
 Citrate bufferNegativeNegative
  (2F, 55%; 3F, 16%; 1F, 12%; other, 17%)(2F, 63%; 3F, 12%; 1F, 8%; other, 17%)
11/EWSR1Tris-EDTA bufferNegativeNegative
  (2F, 80%; 1F, 12%; 1G/1O/1F, 2%; other, 6%)(2F, 75%; 1F, 14%; 1G/1O/1F, 3%; other, 8%)
 Citrate bufferNegativeNegative
  (2F, 79%; 1F, 8%; 1G/1O/1F, 3%; other, 10%)(2F, 78%; 1F, 15%; 1G/1O/1F, 2%; other, 5%)

[i] aThe average copy number of the MDM2 gene in each tumor cell;

[ii] bthe average copy number of chromosome 12 in each tumor cell; and

[iii] cthe amplification ratio of the MDM2 gene in each tumor cell. HIAR, heat-induced antigen retrieval; F, fusion; G, green; O, orange; SS18, synovial sarcoma translocation chromosome 18; MDM2, murine double minute-2; CEP12, chromosome enumeration probe 12; DDIT3, DNA damage inducible transcript 3; EWSR1, Ewing sarcoma breakpoint region 1 gene.

Discussion

Over the decades, precise genome testing has achieved rapid progress, demonstrating great value in definitive and differential diagnoses as well as guidance for therapy for multiple tumor types. FISH is a useful pathological tool for detecting chromosome rearrangement, amplification, gain or deletion and polysomy (8). In the present study, five specific DNA probes extensively used in pathological diagnosis were applied, including EWSR1, TFE3, SS18, DDIT3 and MDM2. Chromosomal rearrangement involving the EWSR1 (22q12) prevalently occurs in Ewing sarcoma, and EWSR1 mostly fuses with FLI1 (11q24) and ERG (21q22) (9). Chromosomal translocation of TFE3 (Xp11.2) is an important characteristic of alveolar soft part sarcoma and microphthalmia transcription factor family translocation renal cell carcinoma (4,10). Recurrent DDIT3 (12q13) rearrangement is commonly regarded as a diagnostic marker for myxoid liposarcoma with high specificity and sensitivity (11). SS18 (18q11) rearrangement occurs in 90% of synovial sarcomas but has not yet been detected in other sarcomas (12). MDM2 gene amplification is an important index for classifying atypical lipomatous tumor/well-differentiated liposarcoma and the amplification level may influence tumor dedifferentiation and progression (13,14).

In laboratory practice, successful FISH detection first requires appropriate sample handling, including fixation, embedding and preservation. Poorly processed FFPE sections frequently fail with regard to signal observation and clinical diagnosis. During tissue fixation, formaldehyde produces inter- and intra-molecular crosslinks in proteins and nucleic acids. Methylene bridges are assumed to be the major structure of those crosslinks and are stable between molecules (15). Inappropriate fixation procedures, such as over-fixation, lead to excessive formation of methylene bridges and a large proportion of nucleic acids may be trapped in protein-protein crosslinks, hampering probe binding to targeted DNA sequences (16). Several troubleshooting tips have been proposed to solve this problem. One recommended method is adjusting the pretreatment and/or digestion time. Conventionally, NaSCN and pepsin are used as pretreatment and digestion reagents, respectively, to cleave crosslinks and increase tissue permeability. In the present study, slides were routinely immersed in NaSCN at 80˚C for 10-15 min and subsequently, tissues were digested with pepsin at 37˚C for 10-15 min. To obtain clear fluorescence signals in the present study, the pretreatment and digestion time was first prolonged in increments of 3-5 min. However, extending the pretreatment time resulted in only minor signal intensity enhancement and long-term (20-25 min) soaking in NaSCN solution always resulted in swollen nuclei, which were difficult to distinguish due to nucleus overlap, particularly in dense connective tissues. Similarly, limited improvement was observed after increasing the duration of digestion. By contrast, excessive digestion led to morphological degradation of nuclei and other strategies were required to be sought to resolve this issue.

Several studies have used a microwave oven during the DNA-DNA hybridization process. In a previous study, intermittent microwave irradiation at 42˚C with a 3-sec irradiation/2-sec stop cycle for 1 h, followed by overnight incubation at 42˚C was employed (17). According to their report, among paraffin blocks yielding no signal in regular FISH, >95% produced acceptable signals following this modified protocol and scanning electron microscopy revealed a looser nuclear matrix in samples exposed to microwave radiation, suggesting a possible mechanism underlying the enhanced probe binding activity (17). In addition, Weise et al (18) compared several different microwave settings during probe hybridization and recommended a treatment of 4-5 times of microwave exposure within 30 min at 600 W. Soriani et al (19) applied the rapid FISH approach by Weise et al (18) to detect chromosome t(15;17)(q24;q21) in acute promyelocytic leukemia and obtained appreciable results.

Prompted by the marked effect of microwave-produced heat in signal retrieval during DNA hybridization, HIAR may be proposed for increasing cell permeability and therefore enhancing specific probe binding ability. It is now generally accepted that the removal of intra-molecular crosslinks depends on the total amount of heat energy applied during the retrieval process instead of the heating device utilized (20). Heating undermines the gel-like structure formed by crosslinks in proteins and nucleic acids, facilitating probe penetration into nuclei and subsequent DNA binding (21). Unlike intermittent microwave irradiation, requiring multiple manual operations and careful temperature monitoring, the present method is relatively easy to follow since HIAR is already widely utilized in immunohistochemistry.

The present study has potential limitations. Up to now, only seven samples for which conventional FISH failed were collected and modified FISH was performed on them. Furthermore, due to the limited number of FFPE slides that were provided for each patient, only one necessary probe was applied to each specimen to guarantee the pathological diagnosis and comparison of signal retrieval efficiency between HIAR- and microwave-assisted FISH was not possible. For cases exhibiting atypical signal patterns, gene rearrangement cannot be validated using other methods, such as RT-PCR or NGS, as no extra sections were available for further assessment. These limitations may be addressed in future research after establishing a larger cohort. However, the current data are encouraging for the use of HIAR in FISH to enhance signal intensity, particularly for challenging specimens in clinical practice.

In summary, HIAR, which has been applied routinely in our laboratory for tumor tissues yielding weak or no signal after a standard FISH workflow, is a reliable tool in clinical FISH detection with high performance in augmenting fluorescence signals.

Acknowledgements

Not applicable.

Funding

This study was supported by the National Natural Science Foundation of China (grant no. 82002829) and the Sanming Project of Medicine in Shenzhen (grant no. SZSM201812076).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

QY, CZ, WH and LL conceived the study. QY and CZ conducted the experiments and interpreted the results. QY performed the literature search, analyzed the data and drafted the manuscript. WH and LL revised the work for important intellectual content. WH and LL confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

The present study was approved by the Medical Ethics Committee of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Shenzhen, China; approval no. 2019-39-2). Written informed consent was obtained from each patient included in this study.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Gu J, Smith JL and Dowling PK: Fluorescence in situ hybridization probe validation for clinical use. Methods Mol Biol. 1541:101–118. 2017.PubMed/NCBI View Article : Google Scholar

2 

Tanas MR, Rubin BP, Tubbs RR, Billings SD, Downs-Kelly E and Goldblum JR: Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: An institutional experience. Arch Pathol Lab Med. 134:1797–1803. 2010.PubMed/NCBI View Article : Google Scholar

3 

Sirvent N, Coindre JM, Maire G, Hostein I, Keslair F, Guillou L, Ranchere-Vince D, Terrier P and Pedeutour F: Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: Utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol. 31:1476–1489. 2007.PubMed/NCBI View Article : Google Scholar

4 

Vargas AC, Selinger C, Satgunaseelan L, Cooper WA, Gupta R, Stalley P, Brown W, Soper J, Schatz J, Boyle R, et al: FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center. Asia Pac J Clin Oncol. 15:38–47. 2019.PubMed/NCBI View Article : Google Scholar

5 

Papp G, Mihály D and Sápi Z: Unusual signal patterns of break-apart FISH probes used in the diagnosis of soft tissue sarcomas. Pathol Oncol Res. 23:863–871. 2017.PubMed/NCBI View Article : Google Scholar

6 

Magaki S, Hojat SA, Wei B, So A and Yong WH: An introduction to the performance of immunohistochemistry. Methods Mol Biol. 1897:289–298. 2019.PubMed/NCBI View Article : Google Scholar

7 

Mascarello JT, Hirsch B, Kearney HM, Ketterling RP, Olson SB, Quigley DI, Rao KW, Tepperberg JH, Tsuchiya KD and Wiktor AE: Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. Section E9 of the American college of medical genetics technical standards and guidelines: Fluorescence in situ hybridization. Genet Med. 13:667–675. 2011.PubMed/NCBI View Article : Google Scholar

8 

Bertram S and Schildhaus HU: Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors. Pathologe. 41:589–605. 2020.PubMed/NCBI View Article : Google Scholar : (In German).

9 

Grünewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E, Kovsar H, Sorensen PH, Delattre O and Dirksen U: Ewing sarcoma. Nat Rev Dis Primers. 4(5)2018.PubMed/NCBI View Article : Google Scholar

10 

Wyvekens N, Rechsteiner M, Fritz C, Wagner U, Tchinda J, Wenzel C, Kuithan F, Horn LC and Moch H: Histological and molecular characterization of TFEB-rearranged renal cell carcinomas. Virchows Arch. 474:625–631. 2019.PubMed/NCBI View Article : Google Scholar

11 

Cheng L, Zhang S, Wang L, MacLennan GT and Davidson DD: Fluorescence in situ hybridization in surgical pathology: principles and applications. J Pathol Clin Res. 3:73–99. 2017.PubMed/NCBI View Article : Google Scholar

12 

Stacchiotti S and Van Tine BA: Synovial sarcoma: Current concepts and future perspectives. J Clin Oncol. 36:180–187. 2018.PubMed/NCBI View Article : Google Scholar

13 

Ware PL, Snow AN, Gvalani M, Pettenati MJ and Qasem SA: MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: Characterizing progression to high-grade tumors. Am J Clin Pathol. 141:334–341. 2014.PubMed/NCBI View Article : Google Scholar

14 

Miura Y, Keira Y, Ogino J, Nakanishi K, Noguchi H, Inoue T and Hasegawa T: Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors. Pathol Int. 62:16–27. 2012.PubMed/NCBI View Article : Google Scholar

15 

Shi SR, Shi Y, Taylor CR and Gu J: New dimensions of antigen retrieval technique: 28 Years of development, practice, and expansion. Appl Immunohistochem Mol Morphol. 27:715–721. 2019.PubMed/NCBI View Article : Google Scholar

16 

Yamashita S and Katsumata O: Heat-induced antigen retrieval in immunohistochemistry: Mechanisms and applications. Methods Mol Biol. 1560:147–161. 2017.PubMed/NCBI View Article : Google Scholar

17 

Sugimura H: Detection of chromosome changes in pathology archives: An application of microwave-assisted fluorescence in situ hybridization to human carcinogenesis studies. Carcinogenesis. 29:681–687. 2008.PubMed/NCBI View Article : Google Scholar

18 

Weise A, Liehr T, Claussen U and Halbhuber KJ: Increased efficiency of fluorescence in situ hybridization (FISH) using the microwave. J Histochem Cytochem. 53:1301–1303. 2005.PubMed/NCBI View Article : Google Scholar

19 

Soriani S, Mura C, Panico AR, Scarpa AM, Recchimuzzo P, Dadati R, Farioli R, De Canal G, Mura MA and Cesana C: Rapid detection of t(15;17)(q24;q21) in acute promyelocytic leukaemia by microwave-assisted fluorescence in situ hybridization. Hematol Oncol. 35:94–100. 2017.PubMed/NCBI View Article : Google Scholar

20 

Yamashita S: Heat-induced antigen retrieval: Mechanisms and application to histochemistry. Prog Histochem Cytochem. 41:141–200. 2007.PubMed/NCBI View Article : Google Scholar

21 

Stumptner C, Pabst D, Loibner M, Viertler C and Zatloukal K: The impact of crosslinking and non-crosslinking fixatives on antigen retrieval and immunohistochemistry. N Biotechnol. 52:69–83. 2019.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

December-2021
Volume 22 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu Q, Zhang C, Huang W and Li L: Heat‑induced antigen retrieval in fluorescence in situ hybridization: An effective approach enhancing signal intensity in poor‑quality FFPE sections. Exp Ther Med 22: 1480, 2021
APA
Yu, Q., Zhang, C., Huang, W., & Li, L. (2021). Heat‑induced antigen retrieval in fluorescence in situ hybridization: An effective approach enhancing signal intensity in poor‑quality FFPE sections. Experimental and Therapeutic Medicine, 22, 1480. https://doi.org/10.3892/etm.2021.10915
MLA
Yu, Q., Zhang, C., Huang, W., Li, L."Heat‑induced antigen retrieval in fluorescence in situ hybridization: An effective approach enhancing signal intensity in poor‑quality FFPE sections". Experimental and Therapeutic Medicine 22.6 (2021): 1480.
Chicago
Yu, Q., Zhang, C., Huang, W., Li, L."Heat‑induced antigen retrieval in fluorescence in situ hybridization: An effective approach enhancing signal intensity in poor‑quality FFPE sections". Experimental and Therapeutic Medicine 22, no. 6 (2021): 1480. https://doi.org/10.3892/etm.2021.10915